On 7 September, he was awarded the “ERS Lifetime Achievement Award in Respiratory Infections” at the ERS Congress 2024.
Led by IDIBAPS-Hospital Clínic Barcelona and carried out on pigs, the study reproduces the characteristics of the disease in humans, which will allow1
One in three patients in the study had a “viral storm”, showing signs of an increased inflammatory response.
Researchers from the Hospital Clínic-IDIBAPS have co-led a document on the management of severe community-acquired pneumonia, published simultaneousl1
Researchers have designed the first ‘living medicine’ to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria whic1
Researchers from Hospital Clínic-IDIBAPS are leading a study that provides new evidence regarding the benefits and risks of corticosteroid treatment,1
Researchers at Hospital Clínic-IDIBAPS are leading the CIBERESUCICOVID project, which seeks to identify the risk and prognosis factors of patients wi1
The study, led by CIBERES, included the participation of IDIBAPS and was published in the Journal of Internal Medicine.
